Epirubicin: Difference between revisions
CSV import |
CSV import |
||
| Line 38: | Line 38: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
== Epirubicin == | |||
<gallery> | |||
File:Epirubicin2DACS.svg|Epirubicin 2D Structure | |||
File:Epirubicin ball-and-stick.png|Epirubicin Ball-and-Stick Model | |||
</gallery> | |||
Latest revision as of 01:26, 20 February 2025


Epirubicin is an anthracycline antibiotic used in cancer chemotherapy. It is a derivative of doxorubicin and is primarily used to treat breast cancer. Epirubicin works by interfering with the DNA replication process, thereby inhibiting the growth and proliferation of cancer cells.
Mechanism of Action[edit]
Epirubicin exerts its effects by intercalating into DNA strands, which disrupts the enzyme topoisomerase II and prevents the DNA from being replicated. This leads to cell death in rapidly dividing cells, such as cancer cells.
Uses[edit]
Epirubicin is used in the treatment of various types of cancer, including:
Administration[edit]
Epirubicin is administered intravenously. The dosage and schedule depend on the type of cancer being treated, the patient's overall health, and other factors. It is often used in combination with other chemotherapy agents.
Side Effects[edit]
Common side effects of epirubicin include:
- Nausea and vomiting
- Hair loss
- Myelosuppression (decreased production of blood cells)
- Cardiotoxicity (damage to the heart muscle)
Precautions[edit]
Patients receiving epirubicin should be monitored for signs of cardiotoxicity, and regular blood tests should be conducted to check for myelosuppression. It is also important to avoid pregnancy while undergoing treatment with epirubicin.
Related Pages[edit]
Categories[edit]
Epirubicin[edit]
-
Epirubicin 2D Structure
-
Epirubicin Ball-and-Stick Model
